Language selection

Search

Patent 3035619 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 3035619
(54) English Title: USE OF MCM7 TO OBTAIN ACETIC ACID-RESISTANT YEAST STRAINS
(54) French Title: UTILISATION DE MCM7 POUR OBTENIR DES SOUCHES DE LEVURE RESISTANTES A L'ACIDE ACETIQUE
Status: Examination
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12Q 1/6809 (2018.01)
  • C7K 14/395 (2006.01)
  • C12N 1/16 (2006.01)
  • C12N 15/31 (2006.01)
  • C12N 15/63 (2006.01)
  • C12P 1/02 (2006.01)
  • C12P 7/06 (2006.01)
  • C12Q 1/68 (2018.01)
(72) Inventors :
  • PIGNEDE, GEORGES (France)
  • DESFOUGERES, THOMAS (France)
(73) Owners :
  • LESAFFRE ET COMPAGNIE
(71) Applicants :
  • LESAFFRE ET COMPAGNIE (France)
(74) Agent: WILSON LUE LLP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2017-08-31
(87) Open to Public Inspection: 2018-03-15
Examination requested: 2022-06-06
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/FR2017/052316
(87) International Publication Number: FR2017052316
(85) National Entry: 2019-03-01

(30) Application Priority Data:
Application No. Country/Territory Date
1658370 (France) 2016-09-08

Abstracts

English Abstract

The invention concerns the use of the MCM7 gene to confer resistance to an organic acid, preferably acetic acid, to a yeast strain during glucose fermentation.


French Abstract

La présente invention concerne l'utilisation du gène MCM7 pour conférer une résistance à un acide organique, avantageusement l'acide acétique, à une souche de levure lors de la fermentation du glucose.

Claims

Note: Claims are shown in the official language in which they were submitted.


35
CLAIMS
1/ Use of the MCM7 gene to confer resistance to an organic acid,
advantageously
acetic acid, to a yeast strain during glucose fermentation.
2/ Use according to claim 1 characterized in that the expression of the
MCM7
gene is induced in the presence of the organic acid.
3/ Use according to claim 1 or 2 characterized in that the sequence
upstream of
the MCM7 gene comprises a binding site for Haal p.
4/ Use according to one of claims 1 to 3, characterized in that the
sequence
upstream of the MCM7 gene comprises the sequence SEQ ID NO: 3 or SEQ ID NO: 4.
5/ Use according to one of claims 1 to 4 characterized in that the yeast
strain
belongs to the group Saccharomyces, advantageously Saccharomyces cerevisiae.
6/ A method for selecting a yeast strain resistant to an organic acid,
advantageously acetic acid, during glucose fermentation, comprising the
following
steps:
- the demonstrated induction of the expression of the MCM7 gene in the
presence of the organic acid; and/or
- the demonstrated presence, at least at one allele of the strain, of a
Haalp
binding site in the sequence upstream of the MCM7 gene, advantageously the
sequence SEQ ID NO: 3 or SEQ ID NO: 4; and/or
- the demonstrated presence, at least at one allele of the strain, of the
presence of a base G at position 624794 on chromosome II.
7/ A method for obtaining a yeast strain resistant to an organic acid,
advantageously acetic acid, during glucose fermentation, comprising the
following
steps:

36
- a sporulation step for two parental strains having different genomes;
- a mass hybridization step for the segregants obtained,
- at least one selection step of segregants because of their capacity to
induce the expression of MCM7 in the presence of the organic acid and/or
because of the presence of a Haalp binding site in the sequence upstream
of MCM7, advantageously the demonstration of the sequence SEQ ID
NO: 3 or SEQ ID NO: 4, and/or because of the presence of a base G at
position 624794 on chromosome II.
8/ The method according to claim 7, characterized in that it comprises the
following steps:
a) prepare segregants from a first parental strain and segregants from a
second parental strain;
b) select from among the segregants from step a) those that can induce the
expression of MCM7 in the presence of the organic acid and/or those
having a Haalp binding site in the sequence upstream of MCM7,
advantageously the sequence SEQ ID NO: 3 or SEQ ID NO: 4, and/or
those having a base G at position 624794 on chromosome II;
c) hybridize the segregants from the first parental strain and selected in
step
b) with segregants from the second parental strain, optionally selected in
step b);
d) select among the hybrids from step c) those resistant to the organic acid.
9/ The method according to one of claims 7 to 8, characterized in that the
first
strain is chosen for its capacity to resist an organic acid and the second
strain for another
characteristic of interest, for example its capacity to metabolize xylose.
10/ The yeast strain according to one of claims 6 to 9 characterized in
that it belongs
to the group Saccharomyces, advantageously Saccharomyces cerevisiae.

3 7
11/ The method according to one of claims 7 to 10, characterized in that
the
first strain is the strain EGAcl deposited at the CNCM under number 1-4839 on
March 13, 2014 and the second strain is the strain deposited at the CNCM under
number 1-4538 on October 5, 2011.
12/ The method according to one of claims 6 to 11, characterized in that
the capacity
to resist the organic acid is tested on a medium comprising glucose.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 03035619 2019-03-01
1
USE OF MCM7 TO OBTAIN ACETIC ACED-RESISTANT YEAST STRAINS
FIELD OF THE INVENTION
The present invention relates to the use of regulation for the expression of
the
MCM7 gene to confer resistance to an organic acid, advantageously acetic acid,
to
a yeast strain during glucose fermentation. Accordingly, the presence, at
least at
an allele, of a binding site for the transcription regulator Haalp upstream of
the
MCM7 gene would induce its expression, which translates by increased
resistance
to the organic acid.
Moreover, the present invention offers a method allowing the genotypic
selection of a yeast strain resistant to an organic acid, advantageously
acetic acid,
during the glucose fermentation. In the same way, the invention allows for
substantial optimization of the yielded yeast strains resistant to an organic
acid,
advantageously acetic acid, based on the genotypic selection of the spores.
BACKGROUND OF THE INVENTION
The capacity of genetically modified yeasts to ferment diverse substrates
makes them a tool of choice in diverse industrial processes, particularly in
the
production of ethanol from lignocellulose biomass. Alcoholic fermentation is
the
process yeasts use in anaerobic media during which sugars are transformed into
alcohol. The yeast Saccharomyces cerevisiae, also known as "baker's yeast,"
remains the microorganism used most often for alcoholic fermentation.
However, some fermentation inhibitors are found naturally in these substrates
and
negatively impact ethanol production. This is in particular the case for weak
organic
acids, particularly for acetic acid, a degradation product of hemicellulose.
When yeasts
are confronted with the presence of organic acid in their environment, they
block their
cellular cycle to be able to prepare to react to this new abiotic stress. The
fermentation
only starts once the cellular resistance machinery is in place. The presence
of a weak

CA 03035619 2019-03-01
2
organic acid accordingly has the consequence of delaying the initiation of the
fermentation on glucose, thereby increasing production costs.
A problem related to acetic acid is all the more crucial since it is a very
powerful
inhibitor for alcoholic fermentation by yeasts and it is found in high
concentrations in
some fermentation media.
Various means have been described to attempt to counter the effect of
fermentation inhibitors, such as for instance detoxifying the fermentation
medium,
or adapting yeasts to fermentation inhibitors by acclimation or genetic
modification.
In the case of acetic acid, detoxifying the fermentation medium is a difficult
option
to implement, particularly industrially. It is therefore necessary to attempt
to modify
the yeasts themselves.
In this context, the acclimation of yeasts can be achieved by adding the
inhibitor into the culture medium, preferably at increasing doses. However, it
has
been observed that yeast adaptation according to this method is only
transient, and
disappears quickly when they are again cultivated in a medium devoid of
inhibitor.
So the method proves to be of little industrial interest, as there
phenotypically
stable strains are necessary.
In the case of sensitivity to acetic acid, only the genetic modification of
yeasts
can therefore be envisaged. This can be done either by modification by genetic
engineering, targeting specific genes, or classically by crossing strains of
interest.
Currently, the molecular mechanisms related to the sensitivity or on the
contrary
the resistance to acetic acid are poorly understood, and insufficient for the
methods
targeted by genetic engineering.
Accordingly, the method of choice to improve resistance to acetic acid remains
yielding yeasts by crossing. However, even though some methods have yielded

CA 03035619 2019-03-01
3
acetic-acid resistant yeast strains, these are by definition random and cannot
guarantee success.
Document WO 2013/178915 describes crossing processes for yeast strains
that allow the production of yeasts that can metabolize glucose and are acetic-
acid
resistant. This method consists in crossing the yeast strain filed at the CNCM
under
the number 1-4538 with the yeast strain filed at the CNCM under the number I-
4627, then in selecting a hybrid that can metabolize xylose and,
independently,
resist acetic acid during the fermentation of glucose.
This hybridization method relies on the capacity of yeasts to reproduce either
asexually, or sexually, according to the culture conditions in particular.
Yeast S. cerevisiae is an organism with a haplodiplontic reproductive cycle,
i.e. an organism capable of actively multiplying both in the haploid and the
polyploid, for example diploid, state.
As long as the medium is favorable, polyploid yeasts are capable of vegetative
multiplication by sprouting giving rise to polyploid yeasts. In the case of a
medium
poor in nitrogen-containing nutrients and containing only a non-fermentable
carbon
source (for example glycerol, acetate, etc.), the heterozygote cells for the
Mat locus
enter into meosis and form yeasts having lower ploidy (spores or segregants)
by a
mechanism called sporulation.
Segregants can multiply by sprouting, giving yeasts having the same genome.
Among haploid yeasts two opposing sexual signs are distinguished, called MATa
and MATa. Two haploid spores with opposite sexual type can fertilize to yield
a
diploid yeast.
The haplodiplontic cycle for S. cerevisiae has been widely used to cross
sexually
compatible segregants (MATa and MATa), particularly in the method called
random

CA 03035619 2019-03-01
4
recombination from mass sporulation and hybridization. In a classic manner,
two
parental diploid strains (different from the genomic point of view) are used.
The
sporulation of parental diploid strains is typically induced by cultivating
them in
conditions where the nitrogen supply is limited and only in the presence of a
non-
fermentable carbon source. The meiosis operating during this step leads to a
genetic
cross-fertilization, creating spores with varied genotype. The spores
(haploid) obtained
for each of the parental strains are then put in contact, to produce diploid
(hybrid) strains
by fusion. This last step is called the hybridization step.
This method is interesting in that it allows the creation of genetic cross-
fertilization from which interesting phenotype traits can emerge. It does
however
require a step of selecting hybrids on the basis of desired phenotype traits.
As an
example, in the case of strictly diploid parental strains each presenting a
phenotype trait
borne by 10 genes, the probability of obtaining the hybrid of interest is
estimated at
1/2.097.106. The final selection step is tedious, long and expensive,
especially.
Therefore, a need exists for improved production methods for acetic-acid
resistant yeast strains.
DESCRIPTION OF THE INVENTION
The inventors have identified that the yeast strains of S. cerevisiae capable
of
having expression of MCM7 induced by an organic acid, particularly acetic
acid,
have a phenotype of resistance to this organic acid. As shown in the
experimental
section, the growth of these strains and their capacity to ferment the glucose
in a
medium rich in acetic acid are improved.
In a particularly interesting manner, the inventors have determined that the
expression of MCM7 in these strains can be induced by acetic acid. In
addition, it
appears that this expression of MCM7, induced by acetic acid, is mediated by
the
transcription factor Haalp. This is particularly surprising, given that MCM7
is not
known as being a gene regulated by Haalp. Accordingly, the work of Mira and

CA 03035619 2019-03-01
collaborators published in 2010 (Mira et al, 2010, OMICS, 14: 587-601)
proposes a list
of genes regulated by Haalp in the strain BY4741, which does not include MCM7.
The
inventors did establish though that in the strains of S. cerevisiae that
resist acetic acid,
the region upstream of the MCM7 coding gene comprises a motif known to be a
binding
5 site for
Haalp. Without being bound to any theory, the presence of this binding site
for
Haalp would be the fruit of single-nucleotide polymorphism (SNPs).
On the basis of these elements, the inventors have developed selection and
production methods for acetic-acid resistant strains of S. cerevisiae.
DEFINITIONS
The term "yeast strain" denotes in the sense of the invention a yeast
population
strictly identical from a genetic point of view. This encompasses both strains
referred
to as laboratory strains and those referred to as industrial strains. This
term is to be
differentiated from the term "yeast," a yeast being obtained by the culture of
a strain as
defined above. In the context of the invention, "yeast" is understood as a
commercial
product obtained by implementation of a production method for a yeast strain.
Thus,
yeasts having different properties can be obtained from a single strain, where
these
differences are connected with the production method implemented.
In the meaning of the invention, a "segregant" is the product of the meiosis
of a yeast strain, regardless of the ploidy level of said yeast. In the
remainder of
the application, the terms "segregant" and "spore" can be used
interchangeably.
The term "yeast strain able to metabolize glucose" denotes in the sense of the
invention a yeast strain capable of converting glucose into ethanol, i.e.
capable of
fermenting glucose. A yeast strain able to metabolize glucose within the
meaning
of the invention is a yeast strain that converts at least 70%, preferably at
least 80%,
and more preferably at least 90% of the glucose into ethanol in 60 hours in a
fermentation medium comprising 150 g of glucose per kg of fermentation medium,
in usual conditions for alcoholic fermentation.

CA 03035619 2019-03-01
6
Preferably, the method used to measure the percentage of glucose converted
into ethanol is as follows:
The yeast strain used is inoculated in synthetic fermentation medium at 0.25 g
of yeast in dry matter / kg of fermentation medium. The 60 hour duration is
calculated
from the inoculation of the fermentation medium with the yeast strain. A
synthetic
fermentation medium is a medium whose exact chemical composition is known. In
the scope of the invention, a synthetic fermentation medium comprises a carbon
source, a nitrogen source, a phosphorus source, and the essential vitamins and
minerals for the growth of a yeast strain. Preferably, the fermentation medium
used to
measure the percentage of glucose converted into ethanol is YF as defined in
the
example embodiments (denoted YF Ac because of the presence of acetic acid).
The fermentation is typically conducted at a temperature comprised between
28 and 37 C, or between 30 and 35 C, advantageously equal to 32 C, with
moderate stirring, for example at 90 or 100 rpm. The stirring is moderate so
as to
not be oxygenating. The pH of the medium is preferably controlled, for example
by the buffering power of an acid/base pair (such as the acetic acid/acetate
pair),
and acid, advantageously comprised between 3.5 and 6, or 4 and 5.5, even more
advantageously equal to 4.4 or 5.
The amount of ethanol present in the fermentation medium is measured by any
appropriate means known to the person skilled in the art. It can be a direct
measurement of the ethanol produced or an indirect measurement through a
parameter correlated to ethanol production, such as CO2 production determined
by
measuring the mass lost. For example, the production of alcohol may be
measured
by chromatography, including HPLC (High Performance Liquid Chromatography),
an enzymatic kit (for example the determination of ethanol by Boehringer kit),
or a
determination by potassium dichromate. The amount of glucose in the
fermentation

CA 03035619 2019-03-01
7
medium is measured by any appropriate means known to the person skilled in the
art, preferably by chromatography, in particular HPLC.
In the context of the invention, "organic acid" or "weak organic acid" is
understood to mean a carboxylic acid that can inhibit the fermentation of a
sugar,
advantageously glucose. It advantageously involves acetic acid, levulinic
acid, or
formic acid, still more advantageously acetic acid.
It should be noted that it is known that only the non-dissociated or non-
ionized form of such acids have inhibition ability. In the context of the
invention,
"un-ionized or non-dissociated form" of a carboxylic acid is understood as the
protonated form thereof. In practice, the form of such organic acids depends
on the
pH of the medium in which they are incorporated. At a pH greater than the pKa
of
the acid, the acid will be mostly found in dissociated form or COO- ions. In
contrast
and at a lower pH, the majority form is the non-dissociated or unionized form
(COOH). In the remainder of the invention, the quantities or concentrations
stated
refer to acetic acid added to the medium, containing dissociated and
undissociated
forms according to the pH of said medium.
The terms "resistant to an organic acid" or "acetic-acid resistant" denote a
yeast strain that can ferment at least one sugar, particularly glucose, with
the
organic/acetic acid having limited impact on the alcoholic fermentation curve.
The
alcoholic fermentation curve representing the quantity of alcohol produced as
a
function of time generally includes three phases: a latency phase during which
there is not ethanol production, an alcohol production phase, and a plateau
phase,
which corresponds to the end of the fermentation.
In a known manner, acetic acid inhibits glucose fermentation, this inhibition
translating as a delay during initiation of fermentation with the kinetics
subsequently remaining unchanged. It should be noted that in the presence of
both

CA 03035619 2019-03-01
8
glucose and xylose in the medium, yeast strains ferment glucose first because
of
catabolite repression.
Accordingly, an "acetic-acid resistant strain" advantageously delays the
initiation of alcoholic fermentation by less than 30 hours, preferably less
than
20 hours, more preferably less than 15 hours, perhaps 10 hours. Preferably,
reference is made to capacity to ferment glucose with a delay in initiation of
alcoholic fermentation as indicated above.
The fermentation medium used to assess resistance to acetic acid is preferably
a
synthetic medium, more preferably the medium YFAc as illustrated in the
embodiment examples. The composition of medium YFAc is as follows: 150 g/kg of
glucose, 5 g/kg of yeast extract, 4.7 g/kg of DAP (diammonium phosphate), 11.4
g/kg
of citric acid, 4 g/kg of acetic acid, 13.5 g/kg of sodium citrate, 1 mL/kg of
Tween 80,
2 mL/kg of ZnSat (at 10.6 g/L), 2.5 ml/kg of MgSO4 7H20 (at 400 g/L), 1 mL/kg
of
thiamine (at 18.24 g/L), 1 mL/kg of pyridoxine (at 5.28 g/L), 1 mL/kg of
biotin (at
1.76 g/L), 1 mL/kg of panthotenate (at 3.8 g/L), 2.5 mL/kg of nicotinic acid
(at 8 g/L),
1 mL/kg of mesoinositol (at 50 g/L), 1 mL/kg of riboflavin (at 1 g/L), 1 mL/kg
of
para-aminobenzoate (at 1.2 g/L), pH adjusted to 4.4 with KOH. The inoculation
of the
yeast strain used to evaluate resistance to acetic acid is preferably 0.25 g
dry matter
/kg of fermentation medium. The time t = 0 of the alcoholic fermentation
corresponds
to the time when the fermentation medium is inoculated with the yeast strain.
Alcoholic fermentation should be conducted preferably at 32 C under medium
stirring, for example 90 rpm.
Note that at the concentration of 2000 ppm, acetic acid does not inhibit the
fermentation. In a suitable manner, acetic acid is added at from 1 to 10 g/kg
of
fermentation medium, for example 4 g/kg of fermentation medium
In the sense of the invention, "MCM7" denotes the gene coding the protein
Mcm7p also called protein Cdc47p, and the product of the expression of this
gene.

CA 03035619 2019-03-01
9
"Gene coding Mcm7p" or "MCM7 gene" are understood in the sense of the
invention the gene of the yeast Saccharomyces cerevisiae located on chromosome
II between the 625767 and 628304 positions, corresponding to ORF (Open Reading
Frame) coding Mcm7p. These positions are indicated in reference to the genome
of
the yeast strain S. cerevisiae S288c, particularly its complete sequence,
available in
the databases under reference GenBank GCA 000146045.2. (version of April 18,
2011), and whose NCBI reference is Gene ID: 852501. The sequence of
chromosome II, used as a reference sequence for numbering, is that accessible
under
number NCBI NC 001134.7 (23/12/2010; SEQ ID NO: 1).
The term "upstream of gene" must be understood in its generally accepted
meaning in molecular biology, i.e. as meaning the region located at 5' (of the
coding strand) of the initiation site for the gene transcription. In a classic
manner,
this region (also called "promoter/regulatory region") is involved in the
expression
of MCM7 gene, comprising in particular promoter and regulatory sequences, such
as binding sites for transcription regulators. In the sense of the invention,
this
region is constituted of the 1200 5' nucleotides at the initiation site of the
transcription of the gene encoding Mcm7p.
"Induction of the expression of MCM7 by or in the presence of an organic acid"
or "overexpression of MCM7 by or in the presence of an organic acid," is
understood
in the presence of the invention to mean an increase in the level of
expression of the
gene encoding Mcm7p in the presence of organic acid, in comparison with the
level
of expression of this gene in the same strain in the absence of the organic
acid. This
increase in expression can translate to the nucleotide level (increased mRNA)
or to
the protein level. The person skilled in the art will therefore be able to
choose the
measurement method that seems the most appropriate to him and the simplest to
implement among the well known methods of molecular biology and biochemistry
(Northern blot, PCR, Western blot, etc.).

CA 03035619 2019-03-01
In the sense of the invention, the terms "induction of the expression of MCM7
mediated by the transcription factor Haa 1 p" or "overexpression of MCM7
mediated by the transcription factor Haalp" mean that the induction of the
expression or the overexpression of MCM7 targeted in the present application
5 depend on transcription factor Haalp. In other words, in the absence of
transcription factor Haalp, for example for the yeasts in which this gene is
deleted
or carries mutation(s) that make it non-functional, or even in conditions
where the
level of Haalp is limited, yeasts are no longer capable of inducing the
expression
of MCM7, in particular in the presence of organic acid.
In the context of the invention, "Haalp binding site" is understood to mean
the nucleotide sequence recognized by the Haalp transcription factor, allowing
it
to bind at the target gene whose transcription level is then regulated by
Haalp.
According to Mira et al. (Nucleic Acid Research, 2011, 39 (16):6896-6907), the
minimum motif recognized by Haa 1 has the following sequence:
5'- (G/C)(A/C)GG(G/C)G - 3'
instead of motif -5'-GNN(G/C)(A/C)(A/G)G(A/G/C)G-3', determined
previously in silico.
DETAILED DESCRIPTION OF THE INVENTION
According to a first aspect, the invention relates to the use of the MCM7 gene
to confer resistance to an organic acid on or to a yeast strain.
According to an advantageous embodiment, the resistance conferred is
resistance to acetic acid, whose presence in high concentrations in the
lignocellulose
hydrolysates is intrinsically related to that of acetyl groups associated in a
covalent
manner with the hemicellulose molecules.
According to another advantageous embodiment, the resistance to the organic
acid in the yeast strain translates during the glucose fermentation, for which
the
delay in initiation of fermentation is lessened or reduced.

CA 03035619 2019-03-01
11
Advantageously, the use of the MCM7 gene is of interest when it is induced,
advantageously in the presence of the organic acid in question, in particular
of acetic
acid.
Even more advantageously, the expression of the MCM7 gene induced by the
presence of the organic acid is mediated by the transcription factor Haalp. In
an
appropriate manner, the sequence upstream of the MCM7 gene comprises a binding
site for Haalp.
According to a specific embodiment, the sequence upstream of the MCM7 gene
comprises the following sequence:
GAGGGG or
GAGGAGGGG or
SEQ ID NO: 2 or
SEQ ID NO: 3 or
SEQ ID NO: 4.
According to another embodiment, the sequence upstream of the MCM7 gene
has at least one of the following characteristics:
- a T at position 624536;
- a T at position 624732;
- a G at position 624736;
- a C at position 624758;
- a G at the 624794 position 624794;
- an A at position 624801;
- an A at position 624832;
- a C at position 625073;
- a G at position 625146;
- an A at position 625199.

CA 03035619 2019-03-01
12
As already stated and in the scope of the invention, the position number
corresponds to that of the reference strain S288c. Therefore "position" must
be
understood as the position, in the strain studied, that corresponds to the
given position.
According to a preferred embodiment, the sequence upstream of the MCM7
gene has at least one G at position 624794. According to another embodiment,
it
has a C at position 624758, a G at position 624794 and an A at position
624801,
or all of the characteristics set out above.
According to a preferred embodiment, the yeast strain targeted by the present
invention belongs to the Hemiascomycetes group. Preferred strains belong to
the
Saccharomyces, Pichia and Yarrowia genera, advantageously Saccharomyces. Among
Saccharomyces, it advantageously concerns Saccharomyces cerevisiae.
According to another feature, the invention concerns a selection process for
a yeast strain resistant to an organic acid comprising:
- the demonstrated induction of the expression of the MCM7 gene in the
presence of the organic acid; and/or
- the demonstrated presence, at least at one allele of the strain, of a
Haalp
binding site in the sequence upstream of the MCM7 gene, advantageously
the sequence GAGGGG or GAGGAGGGG or SEQ ID NO: 2 or SEQ ID
NO: 3 or SEQ ID NO: 4; and/or
- the demonstrated presence, at least at one allele of the strain, of the
presence of a base G at position 624794 on chromosome II.
As already stated, the organic acid is advantageously acetic acid.
According to another preferred embodiment, the resistance to the organic acid
of the resulting selected strain is observed during its glucose fermentation.

CA 03035619 2019-03-01
13
Accordingly, the present invention offers a genotypic screening method for
strains of interest, here resistant to an organic acid. This approach is much
less
expensive, in terms of both time and money, than phenotypic screening
traditionally
used.
As set out, 3 criteria can be evaluated:
The first criterion consists in evaluating the strain's capacity to induce the
expression of MCM7 in the presence of organic acid. As already stated, this
induction of expression can be evaluated by any technique known to the person
skilled in the art at the level of either the transcription or the protein.
The second criterion relies on the presence, at 5' of MCM7, of a Haalp
binding site. Accordingly, and in a suitable manner, the region located
upstream
of MCM7 comprises the sequence (G/C)(A/C)GG(G/C)G, perhaps
GNN(G/C)(A/C)(A/G)G(A/G/C)G (where N is a nucleotide chosen from A, C, G
and T).
According to a specific embodiment, this region contains at least one sequence
chosen from:
- GAGGGG corresponding to a minimum Haalp binding site;
- GAGGAGGGG corresponding to the motif recognized by Haalp,
determined in silico;
- The sequence SEQ ID NO: 2;
- The sequence SEQ ID NO: 3;
- The sequence SEQ ID NO: 4;
advantageously the sequence SEQ ID NO: 3 or 4.
These sequences can be demonstrated by any technique known to the person
skilled in the art such as sequencing, PCR, hybridization.

CA 03035619 2019-03-01
14
As is shown in the example embodiments, this may relate only to one allele
of this strain, perhaps to several, perhaps even to all the alleles (two in
the case of
a diploid yeast).
According to a third criterion, the strain presents, at least at one allele, a
base
G at the position corresponding to the 624794 position of chromosome H,
indicated
in bold in the corresponding sequence in the minimum Haalp binding site
(GAGGGG). Note that an A is observed in this position in non-acetic-acid
resistant
strains. Without wanting to be bound by any category, the replacement of a
base A
by a base G allows the creation of a functional Haalp binding site, allowing
the
induction of the expression of MCM7 in the presence of acetic acid.
Note that other mutations can be found in this region, advantageously chosen
from:
- a T at the 624536 position;
- a T at the 624732 position;
- a G at the 624736 position;
- a C at the 624758 position;
- an A at the 624801 position;
- an A at the 624832 position;
- a C at the 625073 position;
- a G at the 625146 position;
- an A at the 625199 position.
According to a specific embodiment, a strain targeted by the invention is
selected because of the presence of at least one base G at the position
corresponding to the 624794 position of chromosome II, perhaps of at least one
C
at the 624758 position, a G at the 624794 position and an A at the 624801
position,
perhaps even because of the 10 nucleotides mentioned above in relation with
the
specific positions stated, at least in one of its alleles.

CA 03035619 2019-03-01
The demonstration or identification of these mutations is easily achieved by
the person of skill in the art, for example by sequencing the positions of
interest.
The interest of a strain identified using this method can of course be
confirmed by
5 a phenotypic approach, consisting of evaluating the capacity of the strain
selected to
ferment glucose in the presence of acetic acid, for example as described
above.
These various genotypic screening criteria can also be implemented to produce
or obtain yeast strains resistant to an organic acid, advantageously acetic
acid,
10 particularly in the context of glucose fermentation.
Accordingly and using the available molecular biology tools, it is possible to
do
mutagenesis (directed or random) on yeast strains to obtain the desired
phenotype. As
already stated, the presence of the genotypic characteristics stated above is
only a
15 priori necessary at one allele. Alternatively, this mutagenesis can
therefore be
achieved on spores (or segregants) that are then hybridized with other spores,
optionally from another strain presenting another phenotypic trait of
interest.
Advantageously, the invention proposes a method for obtaining a yeast strain
resistant to an organic acid, based on a genotypic screening conducted in
haploid
spores or segregants.
Accordingly and according to another feature, the invention proposes a method
for obtaining a yeast strain resistant to an organic acid comprising:
- a sporulation step for two parental strains having different genomes or
divergent phenotypic traits;
- a mass hybridization step for the spores or segregants obtained,
said process comprising at least one selection step of spores or segregants
because of their capacity to induce the expression of MCM7 in the presence
of organic acid and/or the presence of a Haalp binding site in the sequence
upstream of MCM7, advantageously the demonstration of the sequence

CA 03035619 2019-03-01
16
SEQ ID NO: 3 or SEQ ID NO: 4, and/or the presence of a base G at the
624794 position of chromosome II.
In a characteristic manner, the method of the invention comprises a step of
sporulation of the parental strains. This technique is well known to the
person
skilled in the art and does not therefore require further description. As an
example,
the sporulation step can be conducted by cultivating the parental strains in
appropriate culture conditions, such as for example in a deprived medium.
Among the parental strains, at least one of them has the phenotype of
interest,
here resistance to an organic acid, advantageously acetic acid, in the sense
of the
invention. Advantageously, this delays initiation of alcoholic fermentation
less than
30 h, preferably less than 20 hours, more preferably less than 15 hours
perhaps 10
hours in the fermentation medium YFAc with an inoculum of 0.25 g of dry matter
of yeast /kg of medium. Such strains are well known to the person skilled in
the art.
If need be, the person skilled in the art will be able to produce the parental
yeast
strain resistant to the organic/acetic acid in the sense of the invention, for
example
by the usual techniques using selection pressure.
Note that a parental strain of interest can also be identified using a
selection
method, the subject-matter of the present invention.
In the specific case of the use of S. cerevisiae, it may in particular be
strain
EGAcl filed at the CNCM (Collection Nationale de Cultures de Microorganismes,
Institut Pasteur, 25 rue du Doctor Roux, 75724 Paris Cedex 15) under number I-
4839 on March 13, 2014.
As shown in the context of the present application, where this phenotypic
trait
is optionally carried by only one allele, sporulation gives rise to spores not
bearing
this genotypic trait, here half of the spores in the case of a diploid
parental strain
bearing only one allele with resistance to organic/acetic acid.

CA 03035619 2019-03-01
17
In a specific case, the two parental strains used in the context of the method
of
the invention have a phenotype of resistance to an organic acid in the sense
of the
invention.
In a suitable manner, at least one of the parental yeast strains, particularly
that resistant to organic/acetic acid, advantageously both parental strains,
can
ferment glucose in the sense of the invention.
According to a preferred embodiment, the second parental yeast strain,
advantageously the one not having resistance to organic/acetic acid, has a
second
phenotypic trait of interest. This is for example the capacity to metabolize
pentoses,
particularly glucose present in large quantities in lignocellulose
hydrolysates.
Accordingly, yeast strains that can ferment glucose and also metabolize
pentoses are available:
As an example, document WO 2010/000464 reports obtaining yeast strains
able to ferment pentoses because of a bacterial gene coding for a xylose
isomerase
(XI) which converts xylose into xylulose which can be metabolized by the
yeast.
As an alternative, a eukaryotic pathway should be noted comprising xylose
reductase (XR or XYL1) generating xylitol and a xylitol dehydrogenase (XDH or
XYL2) that can also produce xylulose.
Thus, document WO 2012/072793 describes improved yeast strains combining
exogenous genes coding a xylose isomerase and a xylitol dehydrogenase with
which
to eliminate xylitol which proves to be an inhibitor of xylose isomerase. Such
strains,
in particular the strain registered with the CNCM (Collection Nationale de
Cultures
de Microorganismes) on October 5, 2011 under number 1-4538, have improved
yields
and therefore proven industrial utility for the production of ethanol.

CA 03035619 2019-03-01
18
In that respect and according to a specific embodiment, a second parental
strain
used in the context of the method of the invention is the strain registered
with the CNCM
(Collection Nationale de Cultures de Microorganismes, Institut Pasteur, 25 rue
du
Doctor Roux, 75724 Paris Cedex 15) under number 1-4538 on October 5, 2011.
The method of the invention further comprises a mass hybridization step for
the spores or segregants obtained.
This step is easily carried out according to conventional methods used in the
field and described in detail in chapter 7 "Sporulation and Hybridization of
Yeast"
by R.R. Fowell, in the reference work "The Yeasts", Volume 1, edited by A.H.
Rose and J. S. Harrison, 1969-Academic Press. In brief, the hybridization is
achieved by adding the spores in question to a suitable culture in the
hybridization
step. Typically, the person skilled in the art will be able to use for this
step
complete culture medium of the YPG type (containing 10 g/L yeast extract,
Bactopeptone 20 g/L, glucose 20 g/L and demineralized water qsp 1 L).
The selection step for spores or segregants of interest achieved as described
previously on the basis of at least one of the following 3 criteria:
The first criterion consists in evaluating the spore's capacity to induce the
expression of MCM7 in the presence of organic acid. As already stated, this
induction
of expression can be evaluated by any technique known to the person skilled in
the art
at the level of either the transcription or the protein. It must be understood
that this step
consists in positively selecting the spores or segregants having this
phenotype
(induction of expression of MCM7 by an organic acid, advantageously acetic
acid) i.e.
in isolating spores having this phenotype for the next step.
The second criterion relies on the presence, at 5' of MCM7 of the spore, of a
Haalp binding site. Accordingly, and in a suitable manner, the region located
upstream of MCM7 comprises the sequence (G/C)(A/C)GG(G/C)G, perhaps

CA 03035619 2019-03-01
19
GNN(G/C)(A/C)(A/G)G(A/G/C)G (where N is a nucleotide chosen from A, C, G
and T).
According to a specific embodiment, this region contains at least one sequence
chosen from:
- GAGGGG corresponding to the minimum Haalp binding site;
- GAGGAGGGG corresponding to the motif recognized by Haalp,
determined in silico;
- The sequence SEQ ID NO: 2 or
- The sequence SEQ ID NO: 3 or
- The sequence SEQ ID NO: 4)
advantageously the sequence SEQ ID NO: 3 or 4.
These sequences can be demonstrated by any technique known to the person
skilled in the art such as sequencing, PCR, hybridization.
According to another criterion, the spore has a base G at the position
corresponding to the 624794 position of chromosome II, indicated in bold in
the
corresponding sequence in the minimum Haalp binding site (GAGGGG). Note
that an A is observed in this position in non-acetic-acid resistant spores.
Without
wanting to be bound by any category, the replacement of a base A by a base G
allows the creation of a functional Haalp binding site, allowing the
expression or
overexpression of MCM7 in response to acetic acid.
Note that other mutations can be found in this region, advantageously chosen
from:
- a T at the 624536 position;
- a T at the 624732 position;
- a G at the 624736 position;
- a C at the 624758 position;
- an A at the 624801 position;

CA 03035619 2019-03-01
- an A at the 624832 position;
- a C at the 625073 position;
- a G at the 625146 position;
- an A at the 625199 position.
5
According to a specific embodiment, a segregant targeted by the invention is
selected because of the presence of at least one base G at the 624794 position
of
chromosome II, perhaps of at least one C at the 624758 position, a G at the
624794
position and an A at the 624801 position, perhaps even because of the 10
10 nucleotides mentioned above in relation with the specific positions stated.
The demonstration or identification of these mutations is easily achieved by
the person of skill in the art, for example by sequencing the positions of
interest.
15 A selection
like this can for example be made on the basis of total or partial
sequencing according to the techniques of molecular biology well known to the
person of skill in the art, or by PCR techniques. The sequencing can
accordingly
be achieved by sequencing by hybridization or by high throughput sequencing
techniques such as pyrosequencing, synthetic sequencing or ligation
sequencing.
20 Alternatively, the selection can be made on the basis of PCR techniques by
looking
for the targeted polymorphisms. In this context mention may be made of, for
example, multiplex PCR techniques, which will look for several polymorphisms
in a single test, nested PCR, which produces highly sensitive results, or
colony
PCR, which does not require DNA extraction.
To achieve the sequencing or PCR, a DNA multiplication step may be
necessary, to have sufficient biological material available. It will then be
possible to
proceed with amplification by cultivating each strain or spore in a culture
medium
suitable for its reproduction. Further, a DNA extraction step for yeasts may
be
necessary, and can be done according to molecular biology methods well known
in
the field of the invention.

CA 03035619 2019-03-01
21
The method of the invention can be implemented in diverse ways: the yeast
selection step can be done from parental strains, and/or from spores that come
from
it, and/or from strains obtained after hybridization. As already stated, it is
however
particularly advantageous to proceed with the selection step from spores
coming
from the parental strains.
Thus, according to one preferred embodiment, a method according to the
invention comprises the following steps:
a) prepare segregants from a first parental strain and segregants from a
second
parental strain;
b) select from among the segregants of step a) those that can induce the
expression of MCM7 in the presence of organic acid and/or having a Haalp
binding site in the sequence upstream of MCM7, advantageously the
sequence SEQ ID NO: 3 or SEQ ID NO: 4, and/or having a base G at the
624794 position of chromosome II;
c) hybridize the segregants from the first parental strain and selected in
step b)
with segregants from the second parental strain, optionally selected in step
b);
d) select among the hybrids from step c) those resistant to organic acid.
Step a) of the method corresponds to a preparation step for segregants from
two different parental yeast strains, advantageously S. cerevisiae, i.e. a
sporulation
step. The person skilled in the art will easily be able to obtain segregants
from
parental strains defined above, according to the methods well known in the
field
of the invention.
In an advantageous embodiment, this step comprises the culture of the first
parental yeast strain firstly and the second parental yeast strain secondly,
in a
medium deprived of nitrogen or sugar.

CA 03035619 2019-03-01
22
In a preferred manner, the parental strains used are yeast strains belonging
to
the Saccharomyces group, advantageously Saccharomyces cerevisiae.
According to a preferred embodiment, the first strain is chosen for its
resistance capacity to organic acid, advantageously acetic acid, particularly
during
glucose fermentation. It may in particular be strain EGAc 1 registered with
the
CNCM under number 1-4839 on March 13, 2014. The segregants of this strain will
as a priority be the subject of the selection step b) of the method.
According to another preferred embodiment, the second parental yeast strain
is chosen for another phenotypic trait of interest, for example its capacity
to
metabolize xylose. It can for example be the strain registered with the CNCM
under
number 1-4538 on October 5, 2011.
In a specific case, the second parental yeast may also have resistance
capacity
to organic acid, advantageously acetic acid, particularly during glucose
fermentation. In that case, the spores of this strain will also be the subject
of the
selection step b) of the method.
Step b) of the method of the invention is used as described and allows the
removal of spores that do not have the desired phenotypic trait, here
resistance to
an organic acid in the sense of the invention. Accordingly and thanks to this
step,
the probability of obtaining from the hybridization a strain having this
phenotypic
trait is greatly increased.
Step c) of the method of the invention is a step of hybridization of
segregants
from a first parental yeast strain with segregants from a second parental
strain, where
at least one of the segregant populations has been previously selected in step
b),
advantageously that from the first parental yeast strain.

CA 03035619 2019-03-01
23
Preferably, a mass hybridization is conducted in step c). In other words, step
c) corresponds preferably to a hybridization step for all of the spores from
step b).
Optional step d) of the method consists in selecting among the hybrids from
step c) those capable of alcoholic fermentation and having a phenotype of
resistance to organic acid, advantageously acetic acid. As already stated,
this step
is easily achieved by traditional selection methods, using usual culture
techniques.
This step is advantageously used on a medium comprising glucose.
The present invention is going to be illustrated more ahead using the
following example embodiments, supported by the attached figures. However,
they
have no limiting scope.
LEGENDS FOR THE FIGURES:
Figure 1 shows the flow chart used to determine the proportion of alleles from
EGAcl (1-4839) in yeast populations that fermented in the presence of acetic
acid
(popB) or in yeast populations that fermented without acetic acid (popC) and
along
all of chromosome II.
S288c: strain of S. cerevisiae whose genome serves as GenBank reference
GCA 000146045.2., version of April 18, 2011; NCBI Gene ID: 852501; chromosome
II: NCBI NC 001134.7)
EGAcl: strain registered with the CNCM (Collection Nationale de Cultures de
Microorganismes, Institut Pasteur, 25 rue du Doctor Roux, 75724 Paris Cedex
15)
on March 13, 2014, under number 1-4839.
1-4538: strain registered with the CNCM (Collection Nationale de Cultures
de Microorganismes, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris
Cedex
15) under number 1-4749.
EGAc2: strain registered with the CNCM (Collection Nationale de Cultures de
Microorganismes, Institut Pasteur, 25 rue du Doctor Roux, 75724 Paris Cedex
15)
on March 13, 2014, under number 1-4840.

CA 03035619 2019-03-01
24
Figure 2 shows the frequency averages for alleles in strain EGAcl (1-4839)
in both populations: PopC = not stressed, dotted; PopB = stressed, line
Figure 3 shows
(A) the frequency averages for alleles in strain EGAc 1 (1-4839) in the yeast
populations that fermented in the presence of acetic acid (popB: stressed,
line) or in
the yeast populations that fermented without acetic acid (popC: not stressed,
dotted)
and along all of chromosome II.
(B) the LOD score value (similarity index) as a function of the position along
chromosome II for the 3 series of experiments conducted.
Figure 4 corresponds to
(A) a graphic representation of assembly of genome reads for strain EGAc2
(1-4840) in the 624000 to 626000 bp area of chromosome II of the reference
strain.
The area where the LOD scores are the highest is shown (624500 to 625200 bp;
SEQ ID NO: 3).
(B) a focus on the impact of SNP (A> G) that affects 50% of the alleles in
this
strain in the 624794 position. The arrows represent the presence of a site
recognized
by the Haalp transcription factor in the sequence SEQ ID NO: 2.
Figure 5 relates the average change in mass loss during a fermentation on YFAc
medium at 32 C with an inoculum of 0.25 g/kg (dry matter eq.). The strains
used are:
strain 1-4538, sensitive to acetic acid (S);
strain EGAcl (1-4839), acetic-acid resistant (R);
strain EGAc2 (1-4840) heterozygous, denoted "EGAc2-AlleleR/AlleleS";
strain EGAc2 (1-4840) made homozygous for the allele from EGAel (resistant
allele) at locus 11-624794, denoted "EGAc2-AlleleR/AlleleR";
strain EGAc2 (1-4840) made homozygous for the allele from 1-4538 (sensitive
allele) at locus 11-624794, denoted "EGAc2-AlleleS/AlleleS".
The error bars correspond to standard deviations calculated on the basis of
measurements made with the 7 homozygous strains for the resistant allele and
the 5
homozygous strains for the sensitive allele.

CA 03035619 2019-03-01
EXAMPLE EMBODIMENTS
Example 1: Identification of genetic traits and mutations related to the
phenotype
of resistance to weak organic acids such as acetic acid
5 In these first experiments, the goal is to produce a diverse yeast
population from
a genetic point of view (a), so as not only to select the strains resistant to
weak organic
acids but also to be able to analyze the genetic traits involved in this
phenotype (b).
a. Production of a yeast population comprising strains resistant to weak
10 organic acids:
The yeast population was obtained by random recombination from mass
sporulation and hybridization. This strategy is inspired by the work of Leo
Parts et
al. (2011, Genome Res, 21(7):1131-8). In brief, a segregant (also called
spore) for
an acetic-acid resistant strain (strain EGAc1/1-4839) is crossed with another
15 segregant, from strain 1-4538, thereby creating a first hybrid (strain
EGAc2/1-4840),
as described in W02013/178915.
Secondly, the genome of strain EGAc2 (1-4840) was recombined randomly
to obtain a very diverse yeast population from a genetic point of view. In
practice,
20 hybrid EGAc2 (1-4840) was set to sporulate then the spores obtained were
left to
freely rehybridize among themselves, as described in W02013/178915. The cycle
was reproduced 4 times, thereby generating a 24 reduction in the genetic
distance
in centiMorgan (cM).
25 b. Selection of strains resistant to weak organic acids:
Strains resistant to weak organic acids were selected following the principles
of population genetics, particularly the Hardy-Weinberg principle, which
states
that in an isolated population with unlimited count, not subject to selection,
and in
which there are no mutations, allele and genotype frequencies remain stable
from
generation to generation.

CA 03035619 2019-03-01
26
Accordingly, in the absence of selection, in the case of 2 alleles "A" and
"6,"
where only "A" can play a role in adapting the population at a given selection
pressure
(for example resistance to weak organic acids), the frequencies of allele "A-
and allele
"B" in the population remain stable. By contrast, if the environment changes,
and the
medium is enriched with weak organic acid, then the less adapted strains will
disappear (B) for the benefit of the more adapted strains (A). According to
this
principle, in the case where selection pressure exists, we then observe a
deviation in
this equilibrium over several generations. Accordingly, by comparing the
allele
frequency variations between a population not subjected to the selection and a
population subjected to a selection pressure, one can determine the alleles
that may be
involved in the resistance or adaptation to the selection applied.
In practice, to have a control population, a sample of the population obtained
in point a) was cultivated in a medium devoid of acetic acid (no selection
pressure).
The resulting population is called "population C."
In parallel, a sample of the population obtained in point a) was subjected to
a
high selection pressure by adding acetic acid at the start of the alcoholic
fermentation in the presence of glucose. The resulting population is called
"population B." In practice, acetic acid was added to the culture medium so as
to
obtain a concentration of 4 g/L.
c. Determination of genetic traits involved in the phenotype for resistance to
weak organic acids:
Strain EGAc 1 (1-4839) being acetic-acid resistant, it is expected that the
genetic traits associated with this resistance are present in this strain.
Consequently,
to limit the number of alleles to analyze, one firstly identifies the alleles
specific to
strain EGAcl (1-4839) that are present in strain EGAc2 (1-4840), and in
populations
C and B. Secondly, it is possible to determine the frequency of each of these
alleles
appearing in the stressed (B) or unstressed (C) populations.

CA 03035619 2019-03-01
27
The study of allele frequency variations along the genome was conducted in
the following manner:
After the fermentations, the genomic DNA coming from strain EGAcl (I-
4839), from strain EGAc2 (1-4840) and from populations B and C were extracted
then sequenced by the "Paired End" method using an Illumina HiSeq 2000.
The results were then processed according to the approach illustrated in
Figure 1.
Note that the reference genome is that for strain S288c (GenBank
GCA_000146045.2.,
version of April 18, 2011; NCBI Gene ID: 852501; NCBI NC 001134.7).
In the case of a study conducted on complex populations, the allele frequency
reflects the number of individuals carrying the allele in question. So as an
example
and in direct application of the Hardy-Weinberg principle, if an allele is
present
with a frequency of 70%, it is possible to deduce that 91% of individuals in
the
population carry at least one copy of this allele.
Figure 2 shows how the allele frequency from strain EGAcl (1-4839) changes
along chromosome II and present in populations B and C.
The results in Figure 2 show that in the first portion of chromosome II, the
allele frequencies from EGAcl (I-4839) are very close in both types of
populations
and up to about 530 kb. This observation suggests that the genes present in
this
part of chromosome II (from 0 to 530 kb) would not be involved in the acetic-
acid
resistance process transmitted by the segregant from strain EGAc 1 (1-4839) to
strain EGAc2 (1-4840).
The second part of chromosome II (from 530 kb to 660 kb) shows a
dissociation in curves corresponding to allele frequencies from EGAc 1 (1-
4839) in
both types of populations. This result shows that there is an allele that is
more
represented in the populations subjected to selection pressure than in those
that

CA 03035619 2019-03-01
28
fermented without this pressure. This overrepresentation suggests that this
allele
from EGAc 1 (1-4839) would favor the multiplication of cells in the presence
of
acetic acid. In other words, the second part of chromosome II (from 530 kb to
660 kb) is identified as being a quantifiable genetic trait (also called QTL),
i.e. a
genetic region involved in acetic-acid resistance.
QTL are generally large sequences. One sub-region seems to stand out: this
is the region from bases 624000 to 626000 of chromosome II. This region seems
to include the highest allele frequency variations. Next, it is this sub-
region that
was analyzed.
d. Analysis of genetic traits involved in the phenotype for resistance to
weak organic acids:
Within the QTL, these are more specifically frequency variations for punctual
polymorphisms (SNP for "Single-Nucleotide Polymorphism"), in comparison with
the strains that do not present the phenotypic trait studied, which can be the
most
relevant.
The base pair region 624000 to 626000 of chromosome II was therefore
analyzed in more detail. The similarity index values for the SNPs that it
comprises
were analyzed to target the region comprising the most relevant SNPs in the
phenotype for resistance to weak organic acids (i). Once this region was
identified,
the SNPs that it comprises were analyzed more deeply (ii).
i. Determination of the most region the plus pertinente:
The approach chosen was that of LOD scores, as described by Lander and
Botstein (1989, Genetics, 121:185-99).
The first step consists in determining the inference:

CA 03035619 2019-03-01
29
,
fB = n18
n 1,13-1-1/2,B
= nix
fC
n 1,C+712,C
In the first equation, "n1" is the number of reads bearing the SNP from strain
EGAc 1 (1-4839) in population B and "n2" the number of reads bearing the other
SNP. The next equation relates to the same calculation but applied to the
results of
unstressed populations.
The second step consists in calculating the similarity:
The similarity (L) is defined as being a conditional probability function.
Accordingly, this is the probability of having the allele of strain EGAcl (1-
4839),
either in the population that fermented in the presence of acetic acid, or in
the
population that did not ferment in the presence of acetic acid, calculated
according
to the equations below:
.e(s I fB) = f1?_1(Bilt-B)
14,(cifc)._ fl1(C1If C)
The third step consists in calculating the LOD score:
From these determinations of similarity for each allele, it is now possible to
calculate the LOD for each SNP and to combine it with the allele from strain
EGAcl. The equation used is that published by Lander and Botstein in 1989:
LOD = log L(131fB). L(CITC))
L(B U CI f))
The LOD score was analyzed 3 times on the area of interest for chromosome
II (3 independent experiments). These results are shown in Figure 3. These
results

CA 03035619 2019-03-01
show that when the difference in allele frequency is high, the dispersion of
LOD
scores is also high (principally because of their mathematical and biological
links).
Figure 3B shows that an area comprised between 624500 bp and 625200 bp
5 has high LOD scores that appear reproducible. The most relevant region
identified
is therefore the area between 624500 bp and 625200 bp of chromosome II (SEQ
ID NO: 3).
h. Analysis of SNPs in the most relevant region (between 624500 bp and
10 625200 bp of chromosome II):
The genetic structures present and the SNPs found most frequently in the area
considered (between 624500 bp and 625200 bp of chromosome II) in strain EGAc2
(I-4840) were analyzed.
15 These results are shown in Figure 4.
10 SNPs were identified in the area between 624500 bp and 625200 bp (SEQ
ID NO: 3) of chromosome II:
Position Base in the Mutation
(with reference to strain reference strain
S288e: NC 001134.7;
SEQ ID NO: 1)
624536 A
624732
624736 A
624758
624794 A
624801 G A
624832 C A
625073
625146

CA 03035619 2019-03-01
31
625199 C A
The impact of these SNPs on the sequence of coding areas (open reading frames)
did not show mutations causing changes to the protein sequence.
By contrast, polymorphism (A ->G) in the 624794 position, which affects 50%
of the alleles in strain EGAc2 (1-4840), reconstitutes a site recognized by
the Haalp
transcription factor located upstream of MCM7, and codes a DNA helicase. DNA
helicases replicate DNA and therefore regulate the cell cycle progression and,
consequently, the production of biomass. In other words, yeasts having this
SNP
have a binding site for Haa 1 p transcription factor that the other yeasts do
not have,
upstream of a gene known to play an important role in cellular division.
Accordingly, the fact that the presence of a site recognized Haalp upstream of
MCM7 makes the strains more resistant could hold to the fact that in the
presence of
acetic acid, yeasts carrying this site would multiply more quickly.
Example 2: Validation of the interest of the allele denoted "EGAc1-H-624794"
To take another approach to analyzing the identified area of interest
(particularly
bearing mutations T-> C in the 624758 position, A -> G in the 624794 position
and G
-> A in the 624801 position; SEQ ID NO: 4), it was chosen to achieve the loss
of
heterozygosity in strain EGAc2 (1-4840). Secondly, the performances of strains
made
homozygous for one or other of the two alleles were compared.
a) Construction of homozygous EGAc2 strains for the wild allele or for the
allele comprising the SNP identified as of interest:
Strain EGAc2 (1-4840) is heterozygous for the QTL identified as of interest,
i.e.
bearing the SNP (A ->G) in the 624794 position. Indeed, it has an allele
denoted "II-
624794" of strain EGAc1/1-4839 (i.e. having a G in the 624794 position) and an
allele
"14538-11-624794" from strain 1-4538 (i.e. having an A in the 624794
position). As a
reminder, strain EGAcl (1-4839) is acetic-acid resistant whereas strain 1-4538
is not.

CA 03035619 2019-03-01
32
To better study the role of this mutation, homozygous strains either for
allele
11-624794 of strain EGAcl (denoted "EGAc1-11-624794") or for allele 11-624794
of strain 1-4538 (denoted "14538-11-624794") were prepared. To do this, a
cassette
called LOH was used. In its principle, the cassette LOH is constituted of a
gene
(KanMX4) conferring resistance to geneticin to yeasts that express it. Another
part
of the cassette carries the sequence GIN11m86. The latter is toxic for cells
that
express it (Akada et al., 1997, Mol Gen Genet 254, 267-74; Kawahata etal.,
1999,
Yeast, 15, 1-10 and Akada et al., 2002, Yeast, 19, 393-402). This system is
qualified as dominant negative because a single copy of this sequence is
necessary
to confer the lethal genotype on the cells. In so far as the sequence GIN11m86
is
placed under the dependence of promoter GAL2, it is possible to select on YNB
+
Galactose the cells that would have lost the cassette.
The strategy used to build homozygous EGAc2 strains for allele 11-624794 is
as follows:
The LOH cassette was flanked by recombinogenic sequences capable of
deleting one of the two alleles. The selection of transformants is conducted
on a
YNB-G418 medium (containing geneticin). To determine which of the two alleles
was kept, the locus was amplified by PCR using seeds, called validation seeds,
outside the LOH cassette. The smallest of the resulting PCR fragments (650 bp)
was
cloned in a plasmid pTOPO then sequenced, from which it was determined which
of the two alleles was kept. The strains were retransformed with a sequence
identical
to the allele kept. The new transformants were selected on a YNB medium
containing galactose as only carbon source, allowing the selection of those
that lost
the LOH cassette. Finally, using validation seeds, PCR was again done. The
product
of this reaction is unique and was directly sequenced.
Using this strategy, 7 homozygous EGAc2 strains for allele "EGAcl-II-
624794" (conferring resistance to acetic acid), denoted "EGAc2-
AlleleR/AlleleR",
and 5 homozygous EGAc2 strains for the allele denoted "14538-11-624794"

CA 03035619 2019-03-01
33
(conferring sensitivity to acetic acid), denoted "EGAc2-AlleleS/A1leleS", were
built and validated.
b) Analysis of the impact of homozy2osity on resistance to acetic acid:
After having obtained the 12 previously cited homozygous strains, their
capacity
to ferment glucose in the presence of acetic acid was tested. These
performances were
measured on a YFAc medium (4000 ppm; pH 4.4), defined as follows:
Glucose 150 g/kg
EXL type J100 (Yeast extract) 5 g/kg
DAP (Diammonium phosphate) 4.7 g/kg
Citric acid 11.4 g/kg
Na citrate (sodium citrate) 13.5 g/kg
Acetic acid 4 g/kg
Tween 80 1 mL/kg
ZnSat 10.6 g/L; 2 mL/kg
MgSO4 7H20 400 g/L; 2.5 mL/kg
Thiamine 18.24 g/L; 1 mL/kg
Pyridoxine 5.28 g/L; 1 mL/kg
Biotin (1.76 g/L) + KOH 1 mL/kg
Pantothenate (3.8 g/L) 1 mL/kg
Niacin (8 g/L) 2.5 mL/kg
Myo-inositol (50 g/L) 1 mL/kg
Riboflavin (1 g/L) 1 mL/kg
para-Aminobenzoate (1.2 g/L) 1 mL/kg
The mass loss results observed during the fermentation on this medium are
shown in figure 5. The curves shown are the averages of the values obtained
for
all strains in the same genotype.
The results presented in figure 5 show that strains EGAc2 made homozygous
for the sensitive allele (S) at locus 11-624794 have a delay initiation in
fermentation

CA 03035619 2019-03-01
34
by more than EGAc2 strain (1-4840) on YFAc. This shows that the loss of allele
"EGAc1-11-624794" in a strain EGAc2 for the benefit of a homozygosity of
allele
"14538-11-624794" makes the strains obtained more sensitive to acetic acid
during
the glucose fermentation.
By contrast, the EGAc2 strains made homozygous for allele "EGAc1-11-624794"
at locus 11-624794 have fermentation kinetics on this medium that is not
different than
that of EGAc2 strain (1-4840). This result suggests that the homozygosity does
not add
anything to the strains in this medium.
In conclusion, this work reveals that the allele "EGAc 1 -11-624794" does
indeed
contribute to resistance to strain EGAc2 (1-4840) regarding acetic acid.
However, a
single copy seems to be sufficient to confer a resistance phenotype on acetic
acid.

Representative Drawing

Sorry, the representative drawing for patent document number 3035619 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Amendment Received - Response to Examiner's Requisition 2023-10-11
Amendment Received - Voluntary Amendment 2023-10-11
Examiner's Report 2023-06-23
Inactive: Report - No QC 2023-05-31
Letter Sent 2022-06-29
Request for Examination Received 2022-06-06
Request for Examination Requirements Determined Compliant 2022-06-06
Amendment Received - Voluntary Amendment 2022-06-06
All Requirements for Examination Determined Compliant 2022-06-06
Amendment Received - Voluntary Amendment 2022-06-06
Common Representative Appointed 2020-11-07
Common Representative Appointed 2019-10-30
Common Representative Appointed 2019-10-30
Inactive: IPC assigned 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC removed 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC removed 2019-06-12
Inactive: IPC assigned 2019-06-12
Inactive: IPC removed 2019-06-12
Inactive: First IPC assigned 2019-06-12
Inactive: IPC assigned 2019-06-12
Letter Sent 2019-04-26
Inactive: Single transfer 2019-04-10
Inactive: Notice - National entry - No RFE 2019-03-18
Inactive: Cover page published 2019-03-11
Inactive: First IPC assigned 2019-03-07
Inactive: IPC assigned 2019-03-07
Inactive: IPC assigned 2019-03-07
Application Received - PCT 2019-03-07
National Entry Requirements Determined Compliant 2019-03-01
BSL Verified - No Defects 2019-03-01
Inactive: Sequence listing to upload 2019-03-01
Inactive: Sequence listing - Received 2019-03-01
Application Published (Open to Public Inspection) 2018-03-15

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2023-07-20

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 2019-03-01
Registration of a document 2019-04-10
MF (application, 2nd anniv.) - standard 02 2019-09-03 2019-07-29
MF (application, 3rd anniv.) - standard 03 2020-08-31 2020-07-21
MF (application, 4th anniv.) - standard 04 2021-08-31 2021-07-22
Request for examination - standard 2022-08-31 2022-06-06
MF (application, 5th anniv.) - standard 05 2022-08-31 2022-07-15
MF (application, 6th anniv.) - standard 06 2023-08-31 2023-07-20
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
LESAFFRE ET COMPAGNIE
Past Owners on Record
GEORGES PIGNEDE
THOMAS DESFOUGERES
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 2023-10-10 3 138
Drawings 2023-10-10 5 458
Description 2019-02-28 34 1,346
Claims 2019-02-28 3 84
Abstract 2019-02-28 1 5
Drawings 2019-02-28 5 178
Cover Page 2019-03-10 1 24
Claims 2022-06-05 3 86
Confirmation of electronic submission 2024-07-23 3 77
Notice of National Entry 2019-03-17 1 192
Courtesy - Certificate of registration (related document(s)) 2019-04-25 1 107
Reminder of maintenance fee due 2019-04-30 1 111
Courtesy - Acknowledgement of Request for Examination 2022-06-28 1 424
Examiner requisition 2023-06-22 4 197
Amendment / response to report 2023-10-10 16 808
Patent cooperation treaty (PCT) 2019-02-28 1 39
National entry request 2019-02-28 3 106
International search report 2019-02-28 6 170
Amendment - Abstract 2019-02-28 1 59
Patent cooperation treaty (PCT) 2019-02-28 6 179
Prosecution/Amendment 2019-02-28 1 20
Maintenance fee payment 2019-07-28 1 25
Request for examination / Amendment / response to report 2022-06-05 7 208

Biological Sequence Listings

Choose a BSL submission then click the "Download BSL" button to download the file.

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

Please note that files with extensions .pep and .seq that were created by CIPO as working files might be incomplete and are not to be considered official communication.

BSL Files

To view selected files, please enter reCAPTCHA code :